ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
10 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
73
|
31K
|
10
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
722 |
108K |
0 |
25/07/24 |
25/07/24 |
Sport
|
722
|
108K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
9 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
73
|
31K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
73
|
31K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: CRML Completes Stage 1 Investment for Tanbreez Acquisition
|
|
cuppa
|
12 |
2.6K |
0 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
12
|
2.6K
|
0
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
722 |
108K |
1 |
23/07/24 |
23/07/24 |
Sport
|
722
|
108K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
7 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
73
|
31K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
8 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
73
|
31K
|
8
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
73
|
31K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
73
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW June 2024 quarterly activity report & Appendix 4C
|
|
cuppa
|
8 |
2.4K |
9 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
8
|
2.4K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
73
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW June 2024 quarterly activity report & Appendix 4C
|
|
cuppa
|
8 |
2.4K |
11 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
8
|
2.4K
|
11
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: LU7 Board Visits Operating Refineries in China
|
|
cuppa
|
29 |
13K |
4 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
29
|
13K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
0 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
73
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
0 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
73
|
31K
|
0
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $21 Million Investment Incentive for the Prairie Project
|
|
cuppa
|
71 |
22K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
22K
|
2
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $21 Million Investment Incentive for the Prairie Project
|
|
cuppa
|
71 |
22K |
5 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
22K
|
5
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Lithium Discovery at Prairie
|
|
cuppa
|
75 |
22K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
75
|
22K
|
2
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $21 Million Investment Incentive for the Prairie Project
|
|
cuppa
|
71 |
22K |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
22K
|
1
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Lithium Discovery at Prairie
|
|
cuppa
|
75 |
22K |
1 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
75
|
22K
|
1
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Lithium Discovery at Prairie
|
|
cuppa
|
75 |
22K |
7 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
75
|
22K
|
7
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Diamond drilling commences at CODA
|
|
cuppa
|
54 |
11K |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
54
|
11K
|
2
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Diamond drilling commences at CODA
|
|
cuppa
|
54 |
11K |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
54
|
11K
|
0
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Diamond drilling commences at CODA
|
|
cuppa
|
54 |
11K |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
54
|
11K
|
1
|
|
ASX - By Stock
|
MMR |
Re:
Ann: Reinstatement to trading update
|
|
cuppa
|
12 |
2.8K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
12
|
2.8K
|
2
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Director fees and CEO remuneration
|
|
cuppa
|
18 |
3.2K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
18
|
3.2K
|
6
|
|
Charts
|
ACW |
Re:
ACW Chart Thread
|
|
cuppa
|
69 |
32K |
5 |
09/07/24 |
09/07/24 |
Charts
|
69
|
32K
|
5
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
722 |
108K |
4 |
05/07/24 |
05/07/24 |
Sport
|
722
|
108K
|
4
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Obeikan Group executes Shareholder Agreement
|
|
cuppa
|
30 |
9.6K |
1 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
30
|
9.6K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Biden to volunteer for Xanamem trial ?
|
|
cuppa
|
7 |
2.1K |
1 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
7
|
2.1K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Biden to volunteer for Xanamem trial ?
|
|
cuppa
|
7 |
2.1K |
3 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
7
|
2.1K
|
3
|
|
ASX - By Stock
|
AZL |
Re:
AZL General Discussion
|
|
cuppa
|
22K |
8.0M |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
22K
|
8.0M
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
73 |
31K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
73
|
31K
|
1
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
722 |
108K |
3 |
01/07/24 |
01/07/24 |
Sport
|
722
|
108K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
31K |
0 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
88
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
31K |
5 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
88
|
31K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
31K |
6 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
88
|
31K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
31K |
4 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
88
|
31K
|
4
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: LU7 Board Visits Operating Refineries in China
|
|
cuppa
|
29 |
13K |
2 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
29
|
13K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
31K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
88
|
31K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
31K |
6 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
88
|
31K
|
6
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Prospectus
|
|
cuppa
|
4 |
1.7K |
2 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
4
|
1.7K
|
2
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Prospectus
|
|
cuppa
|
4 |
1.7K |
4 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
4
|
1.7K
|
4
|
|
ASX - By Stock
|
AZL |
Re:
Why do folks only post on a single stock? Beware the pumpers!
|
|
cuppa
|
30 |
6.5K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
30
|
6.5K
|
4
|
|
ASX - By Stock
|
SUV |
Re:
Ann: Market Update
|
|
cuppa
|
22 |
8.3K |
1 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
22
|
8.3K
|
1
|
|
ASX - By Stock
|
SUV |
Re:
Ann: Market Update
|
|
cuppa
|
22 |
8.3K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
22
|
8.3K
|
1
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Phase 1 drilling program commences at CODA
|
|
cuppa
|
299 |
56K |
5 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
299
|
56K
|
5
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Phase 1 drilling program commences at CODA
|
|
cuppa
|
299 |
56K |
3 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
299
|
56K
|
3
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Phase 1 drilling program commences at CODA
|
|
cuppa
|
299 |
56K |
3 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
299
|
56K
|
3
|
|